PhRMA comments on BsUFA

List of 2015 Medicines in Development for Heart Disease and Stroke

Data Exclusivity for Biologics

Biosimilars Naming

Biosimilars 101

What makes Valeant different?

Personalized Medicine: Transforming Patient Care

Joint PhRMA - BIO Letter on IPR

PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders

Washington, D.C. (July 13, 2015) — America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis (MS) and Parkinson’s disease.

Neurological drug list


Subscribe to RSS - Innovation